Dysregulation of the p16ink4A-cyclin D-CDK4/6-RB pathway is common in many cancer types [16] and is recognized in up to 90% of melanomas, with alterations occurring in many nodes of this axis [6,17,18]. The gene discussed is CDKN2A; the disease is melanoma.